The Blue Box
According to the American Cancer Society, one in every eight women will be diagnosed with breast cancer along their lives. This number can be misleading however, as in many cases positive results are actually false positives (is some countries, over 90%). Besides the error margin and the anxiety it can create in the patient, current screening method are painful and costly to public health systems.
The Blue Box proposes a new breast cancer test that is pain-free, accurate and low-cost. Using Artificial Intelligence, it maps and processes key biomarkers from patient biological samples, that are analyzed and digitally shared with patient and doctors in less than an hour.
Judit is a Biomedical Engineer. The fundamental activity of Judit Giró has been exclusively the management of the company since its creation. She worked as an associate engineer at Roche Diagnostics, Barcelona (Spain).In 2019, Judit was awarded a Balsells fellowship to pursue a master’s degree on Embedded and Cyber-Physical Systems at the University of California, Irvine (UCI). There she met Billy, and together they built The Blue Box’s first prototype as their master thesis during the summer of 2020. They co-founded the company in Jan 2021, but Billy left in early 2022. In her TEDx talk, Judit explains her main learnings so far. morePortfolio LinkedIn Instagram Twitter